Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.7799
-0.0011 (-0.14%)
At close: May 12, 2025, 4:00 PM
0.7503
-0.0296 (-3.80%)
After-hours: May 12, 2025, 7:02 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $69.96 million as of May 12, 2025. Its market cap has increased by 237.06% in one year.
Market Cap
69.96M
Enterprise Value
-19.20M
1-Year Change
237.06%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $69.96M, an increase of 37.10%. That is a compound annual growth rate of 9.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 70.06M | -25.62% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |